Diabetes drug can effectively treat fatty liver: Study
Researchers from the King's College London, UK, chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat and liver scarring for people with metabolic dysfunction associated steatohepatitis (MASH) -- a life-threatening form of liver disease.
MASH is a more severe form of Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) -- a long-lasting liver condition caused by having too much fat in the liver.
It is closely linked with obesity as well as conditions such as type 2 diabetes and heart and circulatory disease.
In the trial conducted across 37 countries around the world, 800 participants were randomly assigned to receive a once-weekly injection of 2.4 milligrams of semaglutide or placebo, alongside lifestyle counselling.
The results, published in the New England Journal of Medicine, showed that after 72 weeks of treatment, 62.9 per cent of participants experienced a reduction in steatohepatitis (inflammation of the liver with fat accumulation in the liver) versus 34.3 per cent for participants who took the placebo.
About 37 per cent of the semaglutide group also had improvements in their liver fibrosis versus 22.4 per cent in the placebo group.
"MASLD is a growing problem worldwide and this trial will provide real hope for patients with MASH. While these results must be treated with caution, the analysis shows semaglutide can be an effective tool to treat this advanced liver disease," said Prof Philip Newsome, from King's College.
Researchers also found that people receiving semaglutide had improvements in liver enzymes and other blood measures of liver fibrosis, as well as 10.5 per cent weight loss.
However, gastrointestinal adverse events were more common in the semaglutide group, such as nausea, diarrhoea, constipation, and vomiting, the team said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 hours ago
- Time of India
Earlobe crease a sign of a heart attack or stroke? Expert weighs in
A diagonal earlobe crease, known as Frank's sign, has been linked to an increased risk of heart attack and stroke. Studies suggest a correlation between this crease and vascular issues, with a 2017 study finding a high prevalence of Frank's sign among stroke patients. The human body is quite intricate. It often gives signs before any changes or illnesses occur. When it comes to a heart attack, the signs and symptoms are often subtle and could go unrecognized. But can a crease on the earlobe predict a heart attack? Let's take a look. Crease on the earlobe, aka Frank's sign Some people may have a crease, wrinkle, a line, or a deep fold on their earlobe. This is known as a diagonal ear lobe crease (DELC), or Frank's sign. It's named after Dr. Sander T. Frank, who first observed this crease in 20 patients under 60 with chest pain (angina) and proven coronary artery blockages. Dr. Frank pointed out the link between an earlobe crease and heart disease. He explained it in a paper published in the New England Journal of Medicine in 1973. Following his identification in patients with coronary artery disease, several large studies have documented the presence of a crease in the earlobe in patients with coronary artery disease, peripheral vascular disease, as well as cerebrovascular disease. Many famous people, such as Steven Spielberg and George W. Bush, have DELC. Are these earlobe creases linked with heart disease? Representative image. While studies have shown an association, there is no definitive answer whether DELC is a sign of a heart attack. A 2017 study looked into the link between Frank's sign as a predictor of cerebral vascular events. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Lana Green Is Retiring - Her Final Jewelry Pieces Are 80% Off Artisan Weekly Read More Undo The researchers looked at 241 people hospitalized for acute stroke. Among them, nearly 8 in 10 (190 patients) showed Frank's sign. In 153 patients who had transient ischemic attacks (TIAs), 73% showed the sign. 88 patients had full strokes (cerebrovascular accidents), and 89% showed the sign. Dr. Michael Murray, N.D., a leading authority in Natural medicine, has explained the link in a video shared on Instagram. 'If you have a diagonal earlobe crease, you will have an increased risk of having a heart attack or stroke. Over 40 studies have shown this association. It's not true in every case, but in most cases, it is true. And the reason it is true is that the earlobe is a rich source of vasculature. These blood vessels, if they are not fed with good blood and oxygen, will collapse, and that's what forms that crease,' Dr. Murray said. He further added, 'So there's a physiological and anatomical reason why that earlobe crease develops. You don't want that crease. It is associated with an increased risk of having a heart attack or stroke. No more guesswork: Doctor busts common myths about women's health So take a look. If you have that crease, you need to be more aggressive in diagnostics and determining your vascular function, as well as in your approach to your diet, lifestyle, and supplement strategies for heart health.'
Time of India
a day ago
- Time of India
Fatty Liver: Can apple cider vinegar improve liver health?
Fatty liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), is a growing health concern, affecting an estimated 30.2% of the world's population. Prevalence varies by region, with rates above 40% in the Americas and Southeast Asia. What exactly is Non-Alcoholic Fatty Liver Disease (NAFLD)? Non-alcoholic fatty liver disease (NAFLD) is a condition where excess fat builds up in the liver, not caused by heavy alcohol consumption. It's often linked to obesity, type 2 diabetes, and metabolic syndrome. NAFLD encompasses a spectrum of conditions, from simple fat buildup (NAFL) to more serious inflammation and scarring (NASH), fibrosis, cirrhosis, or may even lead to liver cancer. Now, among many other home remedies that claim natural fixes for fatty liver, apple cider vinegar (ACV) is a popular one. Rich is acetic acid, ACV is frequently touted for its ability to boost metabolism and manage weight. Could this kitchen staple really reduce liver fat and support liver function? Could Apple Cider Vinegar (ACV) help with fatty liver? Apple cider vinegar is a type of vinegar made from fermented apple juice. It's created through a two-step fermentation process, first converting apple juice into alcohol and then into acetic acid, the main component responsible for its sour taste and potential health benefits. Now, multiple animal studies indicate that vinegar, including ACV, helps reduce liver fat and improve metabolic markers: A 2025 study on rainbow trout with NAFLD showed that low-concentration ACV (≈ 2%) significantly reduced steatosis, triglycerides, and enzyme markers (ALT, AST). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Learn More - How Donating Sperm May Boost Your Income SpellRock Undo However, higher doses (≈ 4%) worsened the condition. In rodent models fed a high-fat diet, ACV led to reduced liver fat, improved insulin resistance (lower HOMA‑IR), better lipid profiles, and lowered glucose levels. Liver enzyme levels improved as steatosis decreased from ~56% to ~20% in some studies. These studies suggest that acetic acid in ACV may enhance fat oxidation and reduce metabolic stress. However, these benefits are documented only in animals, not humans. Human research regarding ACV is much more limited. According to a 2021 review of studies , ACV may help decrease cholesterol and fasting glucose. Based on this, apple cider may indirectly help fatty liver disease. However, more research is needed on any direct relationship between apple cider vinegar and fatty liver disease. ACV: Potential benefits and real limitations Possible metabolic support: ACV's acetic acid may help regulate blood glucose and lipid metabolism, especially when combined with calorie control and weight loss efforts. However, the risks weigh heavier. Excessive ACV use can cause tooth enamel erosion, gingival burns, low potassium levels, and digestive discomfort. It can also interact with insulin or diuretic medications, so moderation is crucial. The recommended amount of intake is no more than about 1–2 tablespoons daily, diluted in water. Furthermore, health professionals caution against viewing ACV as a cure, stressing that it's a supplement, not a treatment. How to safely incorporate ACV in your daily diet If you want to try diluted apple cider vinegar: Use raw, unfiltered ACV (with 'the mother') and dilute each tablespoon in a full glass of water. Limit intake to 1–2 tablespoons per day, especially during periods longer than 12 weeks. Take after meals, not on an empty stomach. Rinse your mouth afterward or drink through a straw to protect the tooth enamel. Monitor for side effects: gastrointestinal upset, acid reflux, or electrolyte imbalance. Seek medical advice if you take diabetes or potassium-affecting medications. The information presented in this article is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. No part of this content should be construed as medical advice. If you believe you have fatty liver disease or any other medical condition, consult a professional healthcare provider before making any changes to your diet, supplements, or lifestyle. "Unhealthy Lifestyle Damaging Liver Health
NDTV
2 days ago
- NDTV
Liver Cancer May Kill 1.3 Million By 2050. Here's How to Stop It
A recent study published in The Lancet warns that liver cancer cases worldwide could nearly double by 2050 if current trends continue. New cases may rise from 870,000 to 1.52 million annually, with projected deaths reaching 1.37 million. Liver cancer is now the third deadliest cancer globally. The study highlights preventable causes such as alcohol use, viral hepatitis (B & C), and MASLD, a liver condition linked to obesity. Experts say that 60% of liver cancer cases could be avoided through early prevention and better public health strategies. The report was released on World Hepatitis Day and urges global action to reduce risk factors and improve awareness. Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said. Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added. Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022. Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated. The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said. The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia.
